Sensient Technologies Corporation research snapshot
SXT AI stock analysis as of the August 3, 2026 data cutoff reads Sensient Technologies as a specialty ingredients company riding the strongest growth opportunity in its history, the U.S. and global conversion from synthetic to natural food colors. The stock closed at $123.67 on July 31, 2026, up 31.6% year to date, with a market capitalization near $5.26 billion, re-verified during this full refresh as $123.67 times 42.57 million shares outstanding per the StockAnalysis.com quote and statistics pages. The Q2 2026 report, released July 24, 2026, beat estimates with revenue of $462.1 million versus the $448.8 million consensus and adjusted EPS of $1.20 versus the $1.03 consensus, delivering 10% local currency revenue growth, 21% local currency adjusted EBITDA growth, and 26% local currency adjusted EPS growth, and management raised full-year guidance to local currency revenue up high single to low double digits with adjusted EBITDA and EPS growth in the mid to high teens. The Color Group grew local currency revenue 17.6% and invoiced about $25 million of natural color conversion revenue in Q2, bringing the cumulative total to about $45 million, toward a $1 billion natural color sales goal driven by the U.S. Red 3 ban effective January 2027 for food, beverage, and pet products. Offsetting the momentum is a premium valuation near 33.3x trailing earnings and roughly 1,175x trailing free cash flow, a trailing twelve month free cash flow of only about $4.5 million, planned 2026 capital spending of $150 million to $170 million, and net debt to adjusted EBITDA of 2.3x that management expects to rise into the mid to upper 2s. This page is an informational research tool, not investment advice.
Current price
$123.67 at the July 31, 2026 close
Market cap
$5.26 billion
AI score
68 / 100
Rating
Natural color conversion momentum at a premium valuation
Trend status
Uptrend: price above the 50-day and 200-day moving averages, +31.6% YTD, below the 52-week high of $131.04
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Sensient manufactures and markets colors, flavors, extracts, and specialty ingredients for food, beverage, pharmaceutical, nutraceutical, and personal care customers. FY2025 revenue was $1.61 billion and TTM revenue is $1.70 billion, split across Flavors & Extracts (about $764 million in FY2025), Color (about $680 million), and Asia Pacific (about $168 million), with 4,070 employees and repeat-purchase formulation demand. | High |
| Moat | The moat is moderate: customer relationships, formulation expertise, regulatory approvals for food and pharma ingredients, embedded supply relationships, and a leading position as the worlds largest producer of natural food colorants per Rothschild & Co Redburn. Switching costs are real once a formulation is embedded. No network effects or strong technology patent wall. | Medium |
| Management | Chairman, President, and CEO Paul Manning leads a strategy centered on natural color conversions, describing a strategic shift made over 15 years ago, with CFO Tobin Tornehl alongside. Capital allocation favors heavy capacity investment, about $150 million to $170 million of capex in 2026 and roughly $250 million in natural color capacity over the next few years, no near-term share buybacks, a maintained dividend, and selective acquisitions. Insider ownership is about 1.62%. | Medium-high |
| Financial trend | Q2 2026 revenue grew to $462.1 million from $414.2 million, adjusted EPS of $1.20 beat the $1.03 consensus, and local currency adjusted EBITDA and EPS grew 21% and 26%. The Color Group grew local currency revenue 17.6% with 36.8% operating profit growth. TTM net income is $157.97 million, gross margin 34.7%, operating margin 14.1%, and ROE 13.1%. The weak spot is cash conversion: TTM free cash flow is about $4.5 million and consensus FY2026 free cash flow is forecast near negative $89 million. | High |
| Valuation | At 33.3x trailing P/E, 27.9x forward P/E, 3.1x P/S, 4.2x P/B, and roughly 1,175x trailing P/FCF with a 1.59 PEG, SXT is expensive on almost every metric, above its own FY2025 P/E of 29.7x and above the specialty chemicals peer range. The market is pricing in successful natural color conversion execution. | Medium |
| Technical trend | SXT is in a clear uptrend, up 31.6% year to date and closing at $123.67 on July 31, 2026, above the 50-day moving average near $117.53 and the 200-day near $102.07, with 14-day RSI near 58.9. The 52-week high of $131.04 is the next resistance, and the close sat just below the 5-day average near $123.95. | Medium |
| Risk level | Key risks are execution risk on the $1 billion natural color conversion goal and new capacity, a trailing free cash flow of about $4.5 million with a negative consensus FY2026 free cash flow forecast, leverage expected to rise from 2.3x into the mid to upper 2s, capex of $150 million to $170 million plus roughly $250 million of multi-year natural color investment, non-repeating tariff refunds, raw material and weather supply risk, sluggish food demand, customer concentration in large CPG companies, and an elevated valuation. | Medium |
| AI confidence | High for descriptive facts and cross-checked math that matched across StockAnalysis.com, SEC EDGAR XBRL, the Q2 2026 earnings release, and the Q2 2026 earnings call transcript. Lower for forward return estimates because conversion timing, capacity, and multiples are uncertain. | High data confidence |
| Investment certainty | Medium-low certainty. The page gives scenario ranges and a research framework, not a buy or sell instruction, and the margin of safety is thin at the current multiple. | Medium-low |
SXT AI stock forecast
The SXT AI stock forecast should be read as scenario math, not a price promise. Starting from the July 31, 2026 close of $123.67 and the FY2026 consensus adjusted EPS of $4.12, the three-year framework produces a bearish area near $80 to $95, a base area near $140 to $170, and a bullish area near $190 to $230 before dividends. These outputs depend on EPS compounding, the pace of natural color conversions, capacity execution, raw material and weather risk, leverage, and the exit earnings multiple.
$190 to $230
More likely if natural color conversion revenue accelerates through the January 2027 U.S. deadline and beyond, the Color Group sustains high-teens growth, new capacity fills on time, adjusted EPS compounds near 18% to 20% from the $4.12 consensus toward roughly $7, and the market holds a 28x to 32x multiple on the growth re-rating.
$140 to $170
More likely if Sensient compounds adjusted EPS in the low to mid teens toward roughly $6, matches the raised 2026 guidance of mid to high teen adjusted EBITDA and EPS growth, and investors hold the stock near a 24x to 27x forward multiple, consistent with the analyst average target of $141.20.
$80 to $95
More likely if the natural color conversion slips on technical or supply issues, free cash flow stays deeply negative for multiple years, leverage rises more than guided, a major customer delays a conversion, the sluggish food market persists, or the multiple compresses toward 18x to 20x as growth disappoints.
SXT AI technical analysis
SXT technical analysis as of the July 31, 2026 close shows a strong uptrend with the stock at $123.67, up 31.6% year to date, above both the 50-day moving average near $117.53 and the 200-day moving average near $102.07. The close sat just below the 5-day average near $123.95, and the 52-week high of $131.04 is the immediate resistance. Support clusters at the 20-day and 50-day moving averages near $117.5 to $118, then the 100-day average near $109, then the 200-day near $102. Volume averages roughly 650,000 shares per day, 14-day RSI is near 58.9, and 14-day historic volatility is elevated near 42%. Data cutoff: July 31, 2026 close.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $123.67 | StockAnalysis.com real-time quote at the July 31, 2026 close, with an after-hours print of $123.39; market cap math uses 42.57 million shares outstanding. |
| Resistance (52-week high) | $131.04 | Primary resistance. A breakout above $131.04 with volume would signal bullish continuation toward the analyst average target of $141.20. |
| Resistance (5-day average) | $123.95 | Barchart reported the 5-day moving average near $123.95 on July 31, 2026, just above the close, signaling short-term momentum has cooled after the post-earnings run. |
| Support (20-day and 50-day averages) | $117.5 to $118 | Barchart and StockAnalysis.com both placed the 20-day average near $117.92 and the 50-day near $117.53 on July 31, 2026, forming the first pullback support zone. |
| Support (100-day average) | $109.02 | Barchart reported the 100-day moving average near $109.02, a secondary support if the stock gives back recent gains. |
| Support (200-day average) | $102.07 | Barchart and StockAnalysis.com both reported the 200-day moving average near $102.07, the major trend line for the uptrend. |
| 52-week low | $82.60 | The November 2025 low. A sustained break below the 200-day average would put this zone back in play. |
| Momentum | RSI near 59, ADX near 20 | 14-day RSI near 58.9 on both Barchart and StockAnalysis.com is firm but not overbought, and 14-day ADX near 20.3 on Barchart shows moderate trend strength. |
| Volume | About 650,000 average shares | Barchart listed 20-day average volume near 649,000 shares and StockAnalysis.com near 646,500 on July 31, 2026, useful for checking breakout quality. |
| Volatility | Elevated near earnings | Barchart reported 14-day historic volatility near 42.4%, so position sizing should account for larger swings around earnings and conversion news. |
| Beta (5Y) | 0.77 | The 0.77 beta from StockAnalysis.com means SXT historically moves less than the broad market, consistent with its consumer-linked food ingredients demand. |
| Invalidation | Close below $117 | A decisive close below the 20-day and 50-day moving average cluster near $117.5 to $118 would weaken the short-term uptrend; a close below the 200-day near $102.07 would turn it bearish. |
SXT AI trading strategy
The SXT AI trading strategy framework below is provided for informational reference, not personalized advice. Sensient low beta near 0.77, its 1.33% dividend yield, heavy upcoming capital spending, and natural color conversion catalysts create distinct patterns that traders may incorporate into systematic approaches. Use the Pineify stock screener and Pine Script builder to design and backtest your own strategy conditions.
Enter on a pullback toward the 50-day moving average near $117.53 with the 200-day average near $102.07 rising, and confirm with volume and relative strength. Target a test of the 52-week high at $131.04, then the analyst average target zone near $141. Trail the core position using the 100-day average near $109 as a stop reference.
Risk per trade: 2-3% of capital. Stop loss near $113 or 4% below entry, whichever is lower. Invalidation: price closes below the 100-day moving average near $109, or below the 200-day near $102.
Buy near the 20-day and 50-day support cluster of $117.5 to $118 with confirmation from an oversold RSI reading and a bullish divergence on the daily MACD histogram. Target $123.67 to $128 for a mean reversion. Sell if the support cluster breaks on volume.
Risk per trade: 1-2% of capital. Stop loss near $113. Avoid catching a falling knife if the company reports a natural color conversion setback or a surprise negative on free cash flow.
Hold for the 1.33% dividend yield with quarterly ex-dividend dates, the next being August 3, 2026 with a September 1, 2026 pay date. Covered calls at strikes above $131 can generate additional premium while keeping upside toward the 52-week high open. Monitor the 44.2% payout ratio and the flat dividend, unchanged at $0.41 per quarter since 2022.
Portfolio allocation: 3-5% for income positions. If free cash flow stays negative for several quarters while capex stays elevated, the dividend growth outlook and coverage should be reviewed on each earnings release.
Investment research summary
Sensient sells the colors that make food and beverages look appetizing, the flavors that make them taste consistent, and the specialty ingredients used across pharma, nutraceuticals, and personal care. Customers pay for formulation expertise, regulatory compliance, and supply reliability. The business is a specialty ingredients compounder with a narrow but defensible niche and recurring demand.
Moderate moat from customer relationships, regulatory approvals for food and pharma ingredients, formulation know-how, embedded supply relationships, and a leading natural colorant franchise. Switching costs are real once a color or flavor formulation is embedded in a product. No network effects. Competitors include Givaudan, DSM-Firmenich, and ADM, while IFF has been exiting food ingredients and its functional and natural color assets, reducing one competitor in the category.
The thesis fails if natural color conversions slip on technical or supply challenges, the $1 billion goal proves slower than expected, free cash flow stays deeply negative while capex of $150 million to $170 million a year and roughly $250 million in multi-year natural color investment continue, leverage rises from 2.3x into the mid to upper 2s, a major CPG customer delays a conversion, raw material or weather shocks hit the agricultural supply base, or the market compresses the multiple when growth disappoints.
Chairman, President, and CEO Paul Manning has run a long-term strategy, making a strategic shift to natural colors over 15 years ago, and is now spending heavily to capture it, about $150 million to $170 million of 2026 capex and roughly $250 million over the next few years, with no near-term buybacks, a maintained dividend, and selective acquisitions. CFO Tobin Tornehl runs a balance sheet that management expects to delever over time, and insider ownership is modest near 1.62%.
The industry is in a regulatory and consumer-driven shift from synthetic to natural food colors. The U.S. Red 3 ban takes effect January 2027 for food, beverage, and pet products and January 2028 for pharmaceuticals, Mexico has set a mid-2028 deadline, and Walmart, school lunch programs, and consumer demand are pulling conversions earlier. Sensient targets a $1 billion natural color sales goal, and management points to follow-on waves in pet food, over-the-counter, Latin America, Southeast Asia, China, India, and personal care.
At 33.3x trailing P/E, 27.9x forward P/E, 3.1x P/S, 4.2x P/B, and roughly 1,175x trailing P/FCF with a 1.59 PEG, the market is paying for successful conversion execution. The three-scenario range, roughly $80 to $95 bearish, $140 to $170 base, and $190 to $230 bullish, is wide. The analyst average target of $141.20 sits about 14% above the July 31 close. For a value-oriented investor, the entry price matters more than the story because a large share of the upside is already priced in.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| SXT price | $123.67 at the July 31, 2026 close, $123.39 after hours, up 31.6% year to date | StockAnalysis.com real-time quote and Barchart technical data | August 3, 2026 |
| Market capitalization | $5.26 billion, computed as $123.67 x 42.57 million shares outstanding | StockAnalysis.com quote and share statistics | August 3, 2026 |
| Enterprise value | $6.00 billion | StockAnalysis.com statistics | August 3, 2026 |
| Q2 2026 results | Revenue of $462.1 million versus $414.2 million a year ago and the $448.8 million consensus, adjusted EPS of $1.20 versus the $1.03 consensus, 10% local currency revenue growth, 21% local currency adjusted EBITDA growth, and 26% local currency adjusted EPS growth | Q2 2026 earnings release and earnings call | July 24, 2026 |
| Q2 2026 segment performance | Color Group local currency revenue up 17.6% with operating profit up 36.8% and adjusted EBITDA margin of 28.3%, up 320 bps including a 200 bps benefit from one-time tariff refunds of about $4.3 million; Flavors & Extracts local currency revenue up 3.8% with operating profit up 6.1% and adjusted EBITDA margin of 18.1%; Asia Pacific local currency revenue up 12.3% with operating profit up 23.7% and adjusted EBITDA margin of 24.4% | Q2 2026 earnings call | July 24, 2026 |
| 2026 guidance raised | Local currency revenue up high single to low double digits, and local currency adjusted EBITDA and EPS growth in the mid to high teens, raised from high single to double digit growth | Q2 2026 earnings call | July 24, 2026 |
| Natural color conversion revenue | About $25 million invoiced in Q2 2026, on top of about $20 million cumulative through Q1, for a cumulative total near $45 million, with management saying the Q2 run rate implies roughly $100 million of projected annual revenue toward the $1 billion natural color sales goal | Q2 2026 earnings call | July 24, 2026 |
| Capital spending outlook | Consolidated 2026 capital expenditures of $150 million to $170 million, trending toward the top end, plus roughly $250 million of natural color capital spending over the next few years; Q2 capex was $39 million and Q2 operating cash flow was $48 million | Q2 2026 earnings call | July 24, 2026 |
| Balance sheet and leverage | Net debt to credit adjusted EBITDA of 2.3x as of June 30, 2026, expected to rise into the mid to upper 2s later in the year on higher working capital for natural color conversion; no near-term share buybacks planned | Q2 2026 earnings call | July 24, 2026 |
| Regulatory timeline | U.S. Red 3 ban effective January 2027 for food, beverage, and pet products and January 2028 for pharmaceuticals; Mexico announced a Red 3 ban giving brands until mid-2028 | Q2 2026 earnings call | July 24, 2026 |
| Revenue (TTM) | $1.70 billion, up 8.1% | StockAnalysis.com statistics and financials | August 3, 2026 |
| Net income (TTM) | $157.97 million, up 17.2% | StockAnalysis.com statistics | August 3, 2026 |
| EPS (TTM) | $3.71, up 17.1% | StockAnalysis.com statistics | August 3, 2026 |
| FY2025 revenue | $1.61 billion, up 3.52% from $1.56 billion, matching SEC EDGAR XBRL revenue of $1.612 billion | StockAnalysis.com financials and SEC EDGAR XBRL | August 3, 2026 |
| FY2025 net income | $134.49 million, up 7.88%, matching SEC EDGAR XBRL net income of $134.489 million | StockAnalysis.com financials and SEC EDGAR XBRL | August 3, 2026 |
| FY2025 segment revenue | Flavors & Extracts $763.88 million, Color $680.37 million, Asia Pacific $167.86 million | StockAnalysis.com financials metrics | August 3, 2026 |
| Gross margin (TTM) | 34.88% | StockAnalysis.com statistics | August 3, 2026 |
| Operating margin (TTM) | 14.59% | StockAnalysis.com statistics | August 3, 2026 |
| ROE (TTM) | 13.07% | StockAnalysis.com statistics | August 3, 2026 |
| Cash flow (TTM) | Operating cash flow of $123.37 million, capital expenditures of $118.89 million, and free cash flow of $4.48 million | StockAnalysis.com cash flow statement | August 3, 2026 |
| Cash and cash equivalents | $31.02 million as of June 30, 2026 per StockAnalysis.com, which sources balance sheet data from S&P Global; the Q2 2026 Form 10-Q had not been filed as of the August 3, 2026 data cutoff, so this figure could not yet be cross-checked against a filed 10-Q | StockAnalysis.com statistics and Q1 2026 Form 10-Q | August 3, 2026 |
| Total debt | $763.90 million as of June 30, 2026 per StockAnalysis.com, up from long-term debt of $767.56 million as of March 31, 2026 in the Q1 2026 Form 10-Q | StockAnalysis.com statistics and Q1 2026 Form 10-Q | August 3, 2026 |
| Long-term debt (March 31, 2026) | $767.558 million, matching SEC EDGAR XBRL from the Q1 2026 Form 10-Q | SEC EDGAR XBRL company concept | August 3, 2026 |
| Shares outstanding | 42.57 million shares outstanding with 41.87 million in the float, insider ownership of 1.62%, and institutional ownership of 93.58% | StockAnalysis.com share statistics | August 3, 2026 |
| Valuation check | 33.33x trailing P/E, 27.89x forward P/E, 3.09x P/S, 4.16x P/B, 6.46x P/TBV, 1,174.59x P/FCF, 42.67x P/OCF, 1.59x PEG, and 19.89x EV/EBITDA | StockAnalysis.com statistics | August 3, 2026 |
| Analyst consensus | Buy with an average price target of $141.20 across 5 analysts, a range of $125 to $155, and a median of $140 | StockAnalysis.com forecast and analyst ratings | July 27, 2026 |
| Analyst rating mix, July 2026 | 2 Strong Buy, 1 Buy, 2 Hold, 0 Sell out of 5 analysts | StockAnalysis.com forecast recommendation trends | July 27, 2026 |
| Recent analyst target updates | UBS raised its target to $155 from $143 with a Buy rating on July 27, 2026; Baird raised its target to $140 from $125 with a Buy rating on July 27, 2026; Rothschild & Co Redburn initiated with a Hold rating and $125 target on July 8, 2026 | StockAnalysis.com forecast and news feed | July 27, 2026 |
| 2026 and 2027 consensus estimates | FY2026 revenue forecast of $1.80 billion, up 11.6%, with adjusted EPS of $4.12, up 18.5%, and FY2027 revenue of $2.04 billion with adjusted EPS of $4.90, up 18.8%; consensus FY2026 free cash flow is forecast near negative $89 million | StockAnalysis.com forecast financial forecast | July 27, 2026 |
| Short interest | 1.27 million shares short, 2.99% of shares outstanding and 3.04% of float, about 2.14 days to cover | StockAnalysis.com statistics short selling | August 3, 2026 |
| Dividend | Annual dividend of $1.64 with a 1.33% yield, quarterly payout of $0.41 unchanged since 2022, payout ratio of 44.2%, ex-dividend date August 3, 2026, and pay date September 1, 2026 | StockAnalysis.com dividend page | August 3, 2026 |
| 52-week range | $82.60 to $131.04 | StockAnalysis.com quote | August 3, 2026 |
| Technical snapshot | 5-day SMA near $123.95, 20-day SMA near $117.92, 50-day SMA near $117.53, 100-day SMA near $109.02, 200-day SMA near $102.07, 14-day RSI near 58.87, 14-day ADX near 20.26, 14-day historic volatility near 42.4%, and 20-day average volume near 649,000 shares | Barchart and StockAnalysis.com technical snapshots | August 3, 2026 |
| Employees | 4,070 employees | StockAnalysis.com company profile | August 3, 2026 |
This SXT AI stock analysis is an informational research tool, not investment advice, a recommendation, or a promise of future return. Forecast ranges are scenarios based on available filings, quote snapshots, analyst estimates, and third-party data as of the stated cutoff date. They may be wrong, incomplete, or outdated after new earnings, regulatory developments, market moves, or macro conditions. Past performance does not guarantee future results, and all investment decisions are your own responsibility.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
